These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7915100)

  • 1. Rapid diagnosis of glucocorticoid suppressible hyperaldosteronism in infants and adolescents.
    Jamieson A; Inglis GC; Campbell M; Fraser R; Connell JM
    Arch Dis Child; 1994 Jul; 71(1):40-3. PubMed ID: 7915100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression.
    Jamieson A; Slutsker L; Inglis GC; Fraser R; White PC; Connell JM
    Clin Sci (Lond); 1995 May; 88(5):563-70. PubMed ID: 7614815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.
    Pascoe L; Jeunemaitre X; Lebrethon MC; Curnow KM; Gomez-Sanchez CE; Gasc JM; Saez JM; Corvol P
    J Clin Invest; 1995 Nov; 96(5):2236-46. PubMed ID: 7593610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, biochemical and genetic features of five extended kindred's with glucocorticoid-suppressible hyperaldosteronism.
    Jamieson A; Slutsker L; Inglis G; Campbell M; Fraser R; White P; Connell J
    Endocr Res; 1995; 21(1-2):463-9. PubMed ID: 7588411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity.
    Miyahara K; Kawamoto T; Mitsuuchi Y; Toda K; Imura H; Gordon RD; Shizuta Y
    Biochem Biophys Res Commun; 1992 Dec; 189(2):885-91. PubMed ID: 1472060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting hypertension: the role of the 'new genetics'.
    Jamieson A
    J R Coll Physicians Lond; 1994; 28(6):512-8. PubMed ID: 7884706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.
    Pascoe L; Curnow KM; Slutsker L; Connell JM; Speiser PW; New MI; White PC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8327-31. PubMed ID: 1518866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.
    Ise T; Shimoda A; Takakuwa H; Kato T; Izumiya Y; Shimizu K; Suzuki T; Sasano H; Yokoyama H; Kobayashi K
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):131-4. PubMed ID: 11453962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
    Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid 11 beta-hydroxylase deficiency and related disorders.
    White PC
    Endocrinol Metab Clin North Am; 2001 Mar; 30(1):61-79, vi. PubMed ID: 11344939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.
    Lifton RP; Dluhy RG; Powers M; Rich GM; Cook S; Ulick S; Lalouel JM
    Nature; 1992 Jan; 355(6357):262-5. PubMed ID: 1731223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family hyperaldosteronism type I: a clinical case and review of literature.
    Chikladze NM; Favorova OO; Chazova IE
    Ter Arkh; 2018 Sep; 90(9):115-122. PubMed ID: 30701745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension.
    Jonsson JR; Klemm SA; Tunny TJ; Stowasser M; Gordon RD
    Biochem Biophys Res Commun; 1995 Feb; 207(2):565-71. PubMed ID: 7864844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperaldosteronism suppressible by glucocorticoids. An unusual cause of familial hypertension].
    Pasquet A; Thibaut A; Maiter D; De Plaen JF
    Ann Endocrinol (Paris); 1995; 56(2):149-53. PubMed ID: 7755343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hyperaldosteronism.
    Stowasser M; Gordon RD
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):215-29. PubMed ID: 11595502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of phenotype in patients with glucocorticoid remediable aldosteronism.
    Gates LJ; MacConnachie AA; Lifton RP; Haites NE; Benjamin N
    J Med Genet; 1996 Jan; 33(1):25-28. PubMed ID: 8825044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism.
    MacConnachie AA; Kelly KF; McNamara A; Loughlin S; Gates LJ; Inglis GC; Jamieson A; Connell JM; Haites NE
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4328-31. PubMed ID: 9851772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
    Kamrath C; Maser-Gluth C; Haag C; Schulze E
    Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.